Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?
Knikman, Jonathan E., Gelderblom, Hans, Beijnen, Jos H., Cats, Annemieke, Guchelaar, Henk‐Jan, Henricks, Linda M.
Published in Clinical pharmacology and therapeutics (01.03.2021)
Published in Clinical pharmacology and therapeutics (01.03.2021)
Get full text
Journal Article
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair Analysis
Knikman, Jonathan E, Wilting, Tycho A, Lopez-Yurda, Marta, Henricks, Linda M, Lunenburg, Carin A T C, de Man, Femke M, Meulendijks, Didier, Nieboer, Peter, Droogendijk, Helga J, Creemers, Geert-Jan, Mandigers, Caroline M P W, Imholz, Alexander L T, Mathijssen, Ron H J, Portielje, Johanneke E A, Valkenburg-van Iersel, Liselot, Vulink, Annelie, van der Poel, Marlene H W, Baars, Arnold, Swen, Jesse J, Gelderblom, Hans, Schellens, Jan H M, Beijnen, Jos H, Guchelaar, Henk-Jan, Cats, Annemieke
Published in Journal of clinical oncology (10.12.2023)
Published in Journal of clinical oncology (10.12.2023)
Get full text
Journal Article
A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens
Knikman, Jonathan E, Lopez-Yurda, Marta, Meulendijks, Didier, Deenen, Maarten J, Schellens, Jan H M, Beijnen, Jos, Cats, Annemieke, Guchelaar, Henk-Jan
Published in Clinical pharmacology and therapeutics (01.02.2024)
Published in Clinical pharmacology and therapeutics (01.02.2024)
Get more information
Journal Article